|
|
|||||||||
|
|
NeoReviews Vol.9 No.7 2008 e305
© 2008 American Academy of Pediatrics
* Division of Endocrinology, Department of Pediatrics, Mattel Children's Hospital at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, Calif
Autoimmune thyroid disease is common in pregnancy. Graves disease is present in about 0.2% of pregnancies, and clinical hyperthyroidism occurs in approximately 1% of neonates born to women who have Graves disease. Antibodies to the thyroid-stimulating hormone receptor (TSH-R) (stimulating or blocking) freely cross the placenta and can act in the fetal thyroid gland during the second half of pregnancy. A few cases of fetal hyperthyroidism or hypothyroidism related to maternal TSH-R antibodies (TRAbs) have been reported. Neonatal hyperthyroidism or thyrotoxicosis is usually apparent by 10 days after birth. Such states should be considered emergencies and treated promptly to prevent damage in the newborn.
Abbreviations: ATD: antithyroid drug FT3: free triiodothyronine FT4: free thyroxine T4: thyroxine TRAb: thyroid-stimulating hormone receptor antibody TRH: thyrotropin-releasing hormone TSAb: thyroid-stimulating hormone-stimulating antibody TSBAb: thyroid stimulating hormone-blocking antibody TSH: thyroid-stimulating hormone TSH-R: thyroid-stimulating hormone receptor
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |